Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 04, 2023

BUY
$191.51 - $216.16 $6,894 - $7,781
36 New
36 $7,000
Q1 2023

Apr 19, 2023

BUY
$127.59 - $203.08 $3,572 - $5,686
28 New
28 $5,000
Q2 2021

Jul 14, 2021

SELL
$135.08 - $161.1 $270 - $322
-2 Closed
0 $0
Q1 2021

Apr 19, 2021

BUY
$137.51 - $190.8 $275 - $381
2 New
2 $0

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track International Assets Investment Management, LLC Portfolio

Follow International Assets Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Assets Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on International Assets Investment Management, LLC with notifications on news.